SurgOptix Changes The Way We View Cancer. The goal of the SurgOptix system is to reduce the need for radical excisions of healthy tissue by lighting up tumor cells via fluorescence, thereby allowing for the removal of locally metastasized tumors.

Do You know your Breast Cancer risk?  This first-in-class, scientifically-validated risk assessment test examines a woman's clinical risk factors, such as her lifetime exposure to estrogen, combined with scientifically validated genetic markers to determine each patient's personalized five-year and lifetime risk of developing breast cancer.

 

Breast Density Assessment Article:  Patient education about breast density and its implications is critical. Breast density notification is becoming a reality in many states across the nation by virtue of legislation.

The Latest Mammogram Controversy: Density Many Women Aren't Told Their Breast Type May Cloud Cancer Screening; More States Consider Notification.

Early Breast Cancer Survival Better with Lumpectomy. Women with early-stage breast cancer were more likely to survive if they had a lumpectomy rather than mastectomy.

Low Vitamin D Levels Linked to High Risk of Premenopausal Breast Cancer. Low serum vitamin D levels in the months preceding diagnosis may predict a high risk of premenopausal breast cancer.

Fruit and Vegetable Intake Is Associated With Lower Risk of ER Breast Cancer. Vegetable consumption is associated with a lower risk of estrogen receptor-negative (ER-) breast cancer.

Bioengineers Discover Natural Switch That Controls Spread of Breast Cancer Cells. Biomedical engineers have found the natural switch between the body's inflammatory response and how malignant breast cancer cells use the bloodstream to spread.

New Drug Target for Her-2 Related Breast Cancer. The findings provide a new therapeutic target to block the function of Her2.

New Test Predicted Presence of Harmful BRCA Mutations. A new multiple gene expression profile test was able to predict the presence of harmful BRCA1 or BRCA2 mutations in otherwise healthy women carrying the mutations.

Antiperspirants, Deodorants and Breast Health. The vast majority of over-the-counter deodorants and antiperspirants are made with harmful ingredients that compromise your body's ability to function.

Breast Cancer and Estrogen Connection. Natural estrogen modulators made from cruciferous vegetables such as DIM or I3C along with Calcium D-Glucorate have been lifesaving for many women.

Lung Cancer Deaths Overtaking Breast Cancer Deaths in Women. Lung cancer will soon overtake breast cancer as the top cause of cancer mortality in European women.

Confirmed: MammaPrint Predicts Treatment in Breast Cancer. MammaPrint (Agendia) breast cancer test shows that it can help determine which breast cancer patients can forgo adjuvant systemic treatment.

Inflammatory Breast Cancer: What You Should Know. Data reported at the 2012 San Antonio Breast Cancer Symposium, which showed an association between statin use and disease-free survival (DFS) in patients with IBC.

Stage 1 Breast Cancer Diagnosed by Tomosynthesis in Dense Breasts. Tomosynthesis may assist us in discerning small areas of distortion and spiculation within tissue that appears unremarkable on 2D mammography.

Redirect Breast Cancer Funds, Committee Says. Federal funding for breast cancer research should focus on prevention and understanding how environmental factors influence risk rather than on diagnosis and cure.

Whole-breast ultrasound brings significant screening benefits. This article suggests that freehand ultrasound is not sufficient for whole-breast ultrasound imaging.

Yearly screening breast US benefits women with dense tissue. Although the optimal frequency of screening breast ultrasound for women with mammographically dense breast tissue remains under debate, study data presented at last week's RSNA 2012 meeting suggest that this population would benefit from yearly scans.
 

Researchers at RSNA Determine Molecular Breast Imaging Improves Early Detection in High-Risk Women. 364 high-risk patients who had a recent, negative mammogram underwent an MBI examination. In this group, MBI detected breast cancer in nine patients.

Biopsy Capability Being Developed for Gamma Medica'­s LumaGEM. This new LumaGUIDE hardware and software package, currently a work-in-progress, will allow physicians to precisely identify and biopsy suspicious lesions.

For breast imaging professionals
Credit: 1.0 AMA PRA Category 1; 1.0 ARRT Category A+
Presented by Mary K. Hayes, MD

  Crock Pot Hamburger Soup (click for recipe)

Friend us on Facebook and or Twitter and receive a 10% discount on any new product order!!  Don't forget to request a free sample for the "Try Before you Buy" QSUM satisfaction program. 
               This offer does not include the Breast Self-exam Products as all proceeds are donated to a local charity!